Premium
Anticoagulation Management in the Ambulatory Surgical Setting
Author(s) -
Eisenstein Diana Hill
Publication year - 2012
Publication title -
aorn journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.222
H-Index - 43
eISSN - 1878-0369
pISSN - 0001-2092
DOI - 10.1016/j.aorn.2012.01.018
Subject(s) - medicine , ambulatory , warfarin , low molecular weight heparin , intensive care medicine , venous thromboembolism , heparin , ambulatory care , surgery , thrombosis , health care , atrial fibrillation , economics , economic growth
Many people receiving maintenance anticoagulation therapy require surgery each year in ambulatory surgery centers. National safety organizations focus attention toward improving anticoagulation management, and the American College of Chest Physicians has established guidelines for appropriate anticoagulation management to balance the risk of thromboembolism when warfarin is discontinued with the risk of bleeding when anticoagulation therapy is maintained. The guidelines recommend that patients at high or moderate risk for thromboembolism should be bridged with subcutaneous low‐molecular‐weight heparin or IV unfractionated heparin with the interruption of warfarin, and low‐risk patients may require subcutaneous low‐molecular‐weight heparin or no bridging with the interruption of warfarin. The guidelines recommend the continuation of warfarin for patients who are undergoing minor dermatologic or dental procedures or cataract removal. The literature reveals, however, that there is not adequate adherence to these recommendations and guidelines. Management of anticoagulation therapy by a nurse practitioner may improve compliance and safety in ambulatory surgery centers.